Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli

ABSTRACT The antibacterial activity of rifamycins specifically relies on the inhibition of transcription by directly binding to the β-subunit of bacterial DNA-dependent RNA polymerase (RNAP). However, its killing efficacy is substantially diminished in most gram-negative bacteria. To systematically...

Full description

Bibliographic Details
Main Authors: Yu Wang, Han Fu, Xiao-Jie Shi, Guo-Ping Zhao, Liang-Dong Lyu
Format: Article
Language:English
Published: American Society for Microbiology 2024-01-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02895-23
_version_ 1827383641453363200
author Yu Wang
Han Fu
Xiao-Jie Shi
Guo-Ping Zhao
Liang-Dong Lyu
author_facet Yu Wang
Han Fu
Xiao-Jie Shi
Guo-Ping Zhao
Liang-Dong Lyu
author_sort Yu Wang
collection DOAJ
description ABSTRACT The antibacterial activity of rifamycins specifically relies on the inhibition of transcription by directly binding to the β-subunit of bacterial DNA-dependent RNA polymerase (RNAP). However, its killing efficacy is substantially diminished in most gram-negative bacteria. To systematically reveal the cellular functions that counteract rifamycin-mediated killing in the gram-negative model organism Escherichia coli, we performed a genome-wide Tn5 transposon-mediated screen to identify mutants with altered susceptibility to rifampicin. Combined with targeted gene knockouts, our results showed that the β-barrel assembly machinery plays a crucial role in restricting rifampicin from entering the cell, whereas mutants deficient in other cellular permeability barriers, such as lipopolysaccharide and enterobacterial common antigen, had no such effect. At bactericidal concentrations, the killing efficacy of rifampicin was strongly influenced by cellular functions, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. Although iron acquisition de facto has a strong impact or dependence on cellular redox, our results suggest that their effects on rifampicin efficacy do not rely on hydroxyl radical formation. We provide evidence that maintenance of DNA replication and transcription-coupled nucleotide excision repair protects E. coli cells against rifampicin killing. Moreover, our results showed that sustained aerobic respiration and carbon catabolism diminish rifampicin’s killing efficacy, and this effect relies on the inhibition of transcription but not on translation. These findings suggest that the killing efficacy of rifamycins is largely determined by cellular responses upon the inhibition of RNAP and may expand our knowledge of the action mechanisms of rifamycins. IMPORTANCE Rifamycins are a group of antibiotics with a wide antibacterial spectrum. Although the binding target of rifamycin has been well characterized, the mechanisms underlying the discrepant killing efficacy between gram-negative and gram-positive bacteria remain poorly understood. Using a high-throughput screen combined with targeted gene knockouts in the gram-negative model organism Escherichia coli, we established that rifampicin efficacy is strongly dependent on several cellular pathways, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. In addition, we provide evidence that these pathways modulate rifampicin efficacy in a manner distinct from redox-related killing. Our findings provide insights into the mechanism of rifamycin efficacy and may aid in the development of new antimicrobial adjuvants.
first_indexed 2024-03-08T14:44:17Z
format Article
id doaj.art-b4db7f531a9e4367960e71428cc444cb
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-08T14:44:17Z
publishDate 2024-01-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-b4db7f531a9e4367960e71428cc444cb2024-01-11T14:04:37ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972024-01-0112110.1128/spectrum.02895-23Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coliYu Wang0Han Fu1Xiao-Jie Shi2Guo-Ping Zhao3Liang-Dong Lyu4Key Laboratory of Medical Molecular Virology of the Ministry of Education/National Health Commission, School of Basic Medical Sciences and Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University , Shanghai, ChinaKey Laboratory of Medical Molecular Virology of the Ministry of Education/National Health Commission, School of Basic Medical Sciences and Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University , Shanghai, ChinaKey Laboratory of Medical Molecular Virology of the Ministry of Education/National Health Commission, School of Basic Medical Sciences and Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University , Shanghai, ChinaKey Laboratory of Medical Molecular Virology of the Ministry of Education/National Health Commission, School of Basic Medical Sciences and Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University , Shanghai, ChinaKey Laboratory of Medical Molecular Virology of the Ministry of Education/National Health Commission, School of Basic Medical Sciences and Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University , Shanghai, ChinaABSTRACT The antibacterial activity of rifamycins specifically relies on the inhibition of transcription by directly binding to the β-subunit of bacterial DNA-dependent RNA polymerase (RNAP). However, its killing efficacy is substantially diminished in most gram-negative bacteria. To systematically reveal the cellular functions that counteract rifamycin-mediated killing in the gram-negative model organism Escherichia coli, we performed a genome-wide Tn5 transposon-mediated screen to identify mutants with altered susceptibility to rifampicin. Combined with targeted gene knockouts, our results showed that the β-barrel assembly machinery plays a crucial role in restricting rifampicin from entering the cell, whereas mutants deficient in other cellular permeability barriers, such as lipopolysaccharide and enterobacterial common antigen, had no such effect. At bactericidal concentrations, the killing efficacy of rifampicin was strongly influenced by cellular functions, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. Although iron acquisition de facto has a strong impact or dependence on cellular redox, our results suggest that their effects on rifampicin efficacy do not rely on hydroxyl radical formation. We provide evidence that maintenance of DNA replication and transcription-coupled nucleotide excision repair protects E. coli cells against rifampicin killing. Moreover, our results showed that sustained aerobic respiration and carbon catabolism diminish rifampicin’s killing efficacy, and this effect relies on the inhibition of transcription but not on translation. These findings suggest that the killing efficacy of rifamycins is largely determined by cellular responses upon the inhibition of RNAP and may expand our knowledge of the action mechanisms of rifamycins. IMPORTANCE Rifamycins are a group of antibiotics with a wide antibacterial spectrum. Although the binding target of rifamycin has been well characterized, the mechanisms underlying the discrepant killing efficacy between gram-negative and gram-positive bacteria remain poorly understood. Using a high-throughput screen combined with targeted gene knockouts in the gram-negative model organism Escherichia coli, we established that rifampicin efficacy is strongly dependent on several cellular pathways, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. In addition, we provide evidence that these pathways modulate rifampicin efficacy in a manner distinct from redox-related killing. Our findings provide insights into the mechanism of rifamycin efficacy and may aid in the development of new antimicrobial adjuvants.https://journals.asm.org/doi/10.1128/spectrum.02895-23rifamycinsantibiotic susceptibilitydrug resistanceTn-Seq
spellingShingle Yu Wang
Han Fu
Xiao-Jie Shi
Guo-Ping Zhao
Liang-Dong Lyu
Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
Microbiology Spectrum
rifamycins
antibiotic susceptibility
drug resistance
Tn-Seq
title Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
title_full Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
title_fullStr Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
title_full_unstemmed Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
title_short Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli
title_sort genome wide screen reveals cellular functions that counteract rifampicin lethality in escherichia coli
topic rifamycins
antibiotic susceptibility
drug resistance
Tn-Seq
url https://journals.asm.org/doi/10.1128/spectrum.02895-23
work_keys_str_mv AT yuwang genomewidescreenrevealscellularfunctionsthatcounteractrifampicinlethalityinescherichiacoli
AT hanfu genomewidescreenrevealscellularfunctionsthatcounteractrifampicinlethalityinescherichiacoli
AT xiaojieshi genomewidescreenrevealscellularfunctionsthatcounteractrifampicinlethalityinescherichiacoli
AT guopingzhao genomewidescreenrevealscellularfunctionsthatcounteractrifampicinlethalityinescherichiacoli
AT liangdonglyu genomewidescreenrevealscellularfunctionsthatcounteractrifampicinlethalityinescherichiacoli